A detailed history of Wakefield Asset Management Lllp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Wakefield Asset Management Lllp holds 2,617 shares of MEDP stock, worth $1.06 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
2,617
Previous 3,607 27.45%
Holding current value
$1.06 Million
Previous $1.11 Million 4.34%
% of portfolio
0.37%
Previous 0.42%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$284.87 - $413.31 $282,021 - $409,176
-990 Reduced 27.45%
2,617 $1.06 Million
Q4 2023

Jan 25, 2024

BUY
$227.52 - $312.68 $79,859 - $109,750
351 Added 10.78%
3,607 $1.11 Million
Q3 2023

Nov 01, 2023

SELL
$233.98 - $281.67 $37,670 - $45,348
-161 Reduced 4.71%
3,256 $788,000
Q2 2023

Jul 31, 2023

BUY
$187.26 - $240.17 $2,434 - $3,122
13 Added 0.38%
3,417 $820,000
Q1 2023

May 02, 2023

SELL
$174.31 - $239.52 $28,238 - $38,802
-162 Reduced 4.54%
3,404 $640,000
Q4 2022

Jan 30, 2023

SELL
$153.06 - $226.57 $284,385 - $420,967
-1,858 Reduced 34.26%
3,566 $757,000
Q3 2022

Nov 07, 2022

SELL
$145.13 - $182.49 $3,047 - $3,832
-21 Reduced 0.39%
5,424 $852,000
Q2 2022

Aug 09, 2022

BUY
$130.2 - $168.03 $708,938 - $914,923
5,445 New
5,445 $815,000
Q4 2019

Jan 27, 2020

SELL
$70.08 - $84.64 $470,517 - $568,272
-6,714 Closed
0 $0
Q3 2019

Oct 25, 2019

BUY
$62.38 - $85.89 $418,819 - $576,665
6,714 New
6,714 $564,000
Q2 2019

Aug 13, 2019

SELL
$53.64 - $65.42 $1,716 - $2,093
-32 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$49.38 - $70.58 $398,941 - $570,215
-8,079 Reduced 99.61%
32 $2,000
Q4 2018

Feb 15, 2019

BUY
$46.97 - $63.98 $174,023 - $237,045
3,705 Added 84.09%
8,111 $429,000
Q3 2018

Nov 15, 2018

BUY
$43.25 - $63.74 $190,559 - $280,838
4,406 New
4,406 $264,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.6B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.